Brinton Bio
Built for operators. Designed for investors.
We help biotech companies and portfolio assets scale efficiently, reduce risk, and accelerate value creation.
AI & Life Sciences Strategy for Investors and Innovators.
We work with biotech and pharma executives navigating complex operational change—and with PE and VC investors who need independent expertise on portfolio company performance, due diligence, and value creation.
AI That Actually Works
Most AI initiatives fail because they optimize one dimension (People, Tools, Workflow) while ignoring the others. Real value creation requires equilibrium.
The recent LLM revolution is still fresh, but we are steeped in its strategic design, build, and testing. We have seen the mistakes - repeatedly. We catalogued the lessons learned.
When these three forces reach equilibrium, AI stops being a science project and starts driving measurable results. We design for all three from day one.
AI Discovery Diligence
About 175 AI-originated programs have entered trials since 2019, and none has been approved. Before you fund the next one, find out whether its data can say anything about efficacy.
The Substrate Screen gives investors and pharma BD teams an independent read in one to two weeks: a four-property grade of the training data, whether the endpoint is a number the body defends, and whether the data encodes the mechanism being predicted.
On the Record
The AI Drug Discovery Race Is Heating Up, Not In the Way You Think
MedCity News, June 2026. About $60B deployed since 2019 and no approvals yet. The bets that pay are the ones whose training data encodes the mechanism.
Working Note No. 05: Where AI Bends Nature
Brinton Bio Working Notes, May 2026. Why AlphaFold worked, and why most pharma AI hasn’t. The substrate decides.
Catalyzing Novel Approaches to Rapid, Accurate, and Affordable Early Cancer Detection
The Cancer Journal, 2018. Peer-reviewed. Senior author.
Scientific Spokesperson + Architect, Cancer XPRIZE
Public voice for a global prize competition in cancer innovation.
